It has been found that blocking the CCL3-CCR1/CCR5 and CXCL12-CXCR4 axes can slow down AML progression by inhibiting the migration of Tregs into the leukemic hematopoietic microenvironment (94). The gene discussed is CXCR4; the disease is acute myeloid leukemia.